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Scientific Abstracts potential predictor of disease activity and response to treatment in inflammatory diseases. In Juvenile Idiopathic Arthritis (JIA), MRP8/14 levels are highly predictive of disease flares in systemic JIA. In a more heterogeneous group of JIA patients (pts), MRP8/14 levels have been shown to predict response to MTX. High levels of baseline MRP8/14 are associated with good response to anti-TNF treatment, whereas elevated MRP8/14 levels at time of discontinuation are associated with higher chance to flare. In clinical practice, ultrasound could be usefull to define the state of disease activity. Indeed, PD-US assessment of synovial vascularization has been shown to be more sensitive than serum markers of inflammation in the identification of active disease in JIA. Background: Juvenile idiopathic arhritis (JIA) is an inflammatory arthritis that begins before 16 years of age and persists more than 6 weeks. The prevalence of JIA is approximately 1 to 2 per 1,000 children. Only 40-60% of JIA patients had inactive disease at follow-up (1). An increase rate of mortality has been observed in JIA. A follow-up study in the United States reported early deaths especially in systemic JIA (2). The same was found in an follow-up study in Scotland (3). However two follow -up studies in United States and one study in Germany showed no increased mortality (4,5,6). Objectives: To explore mortality rates and causes of death in JIA patients in Finland compared with the general population. Methods: All incidents patients with JIA during 2000-2014 were collected from the nationwide register of special reimbursements for disease-modifying antirheumatics drugs, maintained by the Social Insurance Institution of Finland. The National Population Registry identified three age, sex and residence matched controls for each case. Death certificate data up to 2015 were obtained from the Statistics of Finland. Results: Altogether 4,180 JIA patients (62% girls) were identified. Mean age at diagnosis was 8.3 years. The average follow-up was 6.6 years (IQR 3.1-10.5). These patients were compared with 12,511 controls. During 28.941 follow-up years, 11 JIA patients (6 girls, 5 boys) and 23 controls (12 girls, 11 boys) died. Mean age at death was 20.3 years (range 11-30) in the JIA patients and 23.1 years (range 9-29) years in the control group. (p=0.17). Cumulative mortality in the patients with JIA was 0.4% (95% Cl 0.2-0.8%) compared to 0.3% (95% Cl 0.2-0.5%) in the controls, hazard ratio was 1.44 (95% Cl 0.70-2.95).
Accidents were the most common (54%) cause of death in the patients with JIA, but suicide (39%) in the controls. Alcohol, drug abuse and depression contributed more to deaths in the control (39%) than in JIA group (1%), p=0.053. Conclusions: Juvenile idiopathic arthritis is not associated with a higher mortality rate in children and young adults. Patients with other causes of dyslipidemia or those whom receiving vitamin D supplements or lipid-lowering medications were excluded from this study. Systolic and diastolic blood pressure was measured to all patients and controls Also; all patients and controls underwent laboratory tests of plasma 25(OH)D, Serum High-Density Lipoprotein (HDL), Low-Density Lipoprotein cholesterol (LDL). Echocardiography, carotid intima media thickness (cIMT), flow mediated dilatation of the brachial artery (FMD) also was done to all patients and controls. Vit D levels were then correlated in each subgroup with the other clinical, laboratory and radiological parameters. We predefined Vit D insufficiency as being <50 nmol/l and Vit D deficiency as being <25 nmol/l. Results: The mean serum vitamin D levels of all patients were 23.8 nmol/l ±16.59. Only 7patients (23.3%) have adequate vitamin D levels (50-75 nmol/l). While Vitamin D insufficiency (serum vitamin D: 25 -50 nmol/l) and deficiency (serum vitamin D level <25 nmol/l) were found in 9 (30%) and 14 patients (46.7%), respectively. JIA patients had significantly lower vitamin D levels as compared to controls (p<0.01). JIA patients had higher systolic and diastolic blood pressure than controls although these differences were not statistically significant (p>0.05) and all levels were still in normal values. Subjects with vitamin D deficiency or insufficiency had significantly lower values for HDL cholesterol and significantly elevated values for LDL cholesterol as compared to controls and patients with adequate vitamin D levels, with significant positive correlation between 25(OH)D and HDL cholesterol, and significant inverse correlation between 25(OH)D and LDL levels. Patients with lower levels of vitamin D had significantly higher cIMT and lower FMD (p<0.01) With significant positive correlation between 25(OH)D and FMD, and significant inverse correlation between 25(OH)D and cIMT, while there were no significant differences in echocardiography results. 
